Gibbons on helium sing like opera stars
LONDON (Reuters) - Gibbons are jungle divas. The small apes use the same technique to project their songs through the forests of southeast Asia as top sopranos singing at the...
Home > Reviews
All Stories
Showdown for Big Pharma in India’s highest court
MUMBAI/LONDON (Reuters) - India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector...
Showdown for Big Pharma in India’s highest court
MUMBAI/LONDON (Reuters) - India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector...
GSK drug halves attacks in hard-to-treat asthma
LONDON (Reuters) - An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a...
GSK drug halves attacks in hard-to-treat asthma
LONDON (Reuters) - An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a...
European regulators back first gene therapy drug
LONDON (Reuters) - European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous occasions -- in a significant advance for...
European regulators back first gene therapy drug
LONDON (Reuters) - European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous occasions -- in a significant advance for...
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON (Reuters) - GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile...
Exclusive: GSK set for Human Genome takeover – sources
NEW YORK/LONDON (Reuters) - GlaxoSmithKline is expected to announce an agreement to acquire Human Genome Sciences for about $2.8 billion as soon as Monday, ending three months of its hostile...
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON (Reuters) - GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile...